Equibles does not estimate personal net worth.
Get an email with a short summary when Recursion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get RXRX alertsChristopher C. Gibson is recorded as Board Member at Recursion Pharmaceuticals, Inc. (RXRX) since January 1, 2013 and CEO at Recursion Pharmaceuticals, Inc. (RXRX). The proxy statement of Recursion Pharmaceuticals, Inc. reports total compensation of $9,607,508 for Christopher C. Gibson in fiscal 2025, including a base salary of $680,000. Disclosed compensation is on record for 6 fiscal years. Christopher C. Gibson has spoken on 2 earnings calls across 1 company, most recently for Recursion Pharmaceuticals, Inc. on November 5, 2025. Recursion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Recursion Pharmaceuticals, Inc. includes Najat Khan (CEO), Najat Khan, Ph.D. (CEO and Board Member), Christopher Gibson, Ph.D. (Chairman) and 7 others.
“I'm the Co-Founder and current CEO of Recursion, and I'm so delighted to have you all joining us today. I want to start off by talking about something that I'm really excited about, which is our executive leadership updates.”
“And I'm excited to share with you today some of the latest updates on our company as we drive forward to decode biology. We've been talking for the last 9 months since the business combination with Exscientia about the Recursion OS 2.0.”
2013-01-01–present
Biotechnology · Healthcare
CEO, Board Member
2013-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Recursion Pharmaceuticals, Inc. (RXRX) | former Chief Executive Officer and President and current Chair of the Board | $680,000 | $9,607,508 |
| 2024 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $600,000 | $8,499,587 |
| 2023 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $560,833 | $8,613,209 |
| 2022 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $497,500 | $6,315,903 |
| 2021 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $485,417 | $673,591 |
| 2020 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Executive Officer | $269,643 | $2,584,448 |
